TRANSMEDICS GROUP, INC.

Lobbying client · Massachusetts · filed 2026 to 2026

Commercial-stage medical technology company transforming organ transplant therapy.

$260,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (72072), not by name.

Firms hired 1

AKIN GUMP STRAUSS HAUER & FELD $260,000 3 filings

Reported by year 1 year

2026 $260,000 3 filings

Issues lobbied 1

Medical/Disease Research/Clinical Labs 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Centers For Medicare and Medicaid Services (CMS) 2
Health Resources & Services Administration (HRSA) 2
HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

Q2

AKIN GUMP STRAUSS HAUER & FELD

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $130,000 income · posted Jul 20, 2026

View → Q1

AKIN GUMP STRAUSS HAUER & FELD

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $130,000 income · posted Apr 20, 2026

View → RR

AKIN GUMP STRAUSS HAUER & FELD

1st Quarter (Jan 1 - Mar 31) 2026 · posted Mar 30, 2026

View →

Affiliated organisations 1

TRANSMEDICS, INC. United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.